糖尿病照护设备市场 - 按产品（血糖监测设备、胰岛素输送设备）、最终用途（医院、诊断中心） - 全球预测，2024 年 - 2032 年

Diabetes Care Devices Market - By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices ), End-Use (Hospitals, Diagnostic Centers) - Global Forecast, 2024 - 2032

出版日期: 2024年02月07日 | 出版商:

Global Market Insights Inc. | 英文 257 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于久坐的生活方式和不健康的饮食习惯，全球糖尿病盛行率不断上升，预计从 2024 年到 2032 年，糖尿病照护设备市场规模将以 10% 的CAGR扩大。根据 CDC 的数据，美国共有 3,840 万人患有糖尿病。不断进步的技术发展正在促进更高效和用户友好的设备的开发，以提高患者的依从性和采用率。

人们越来越认识到糖尿病患者定期监测和管理血糖水平的重要性，这将增加对这些设备的需求。许多地区实施糖尿病护理优惠报销政策以及容易患糖尿病相关併发症的老年人口不断增加也将补充行业的发展。

糖尿病护理设备市场按产品、最终用途和地区划分。

就产品而言，到2032年，胰岛素输送设备领域的市场价值将以10.2%的增长率增长。技术创新正在导致更用户友好和方便的胰岛素输送设备的开发。全球糖尿病盛行率不断上升，加上胰岛素治疗的日益普及，正在加速胰岛素输送设备的吸引力。提高患者对胰岛素治疗依从性的措施的跃进也将扩大产品的采用。

预计在 2024 年至 2032 年间，家庭护理最终用途领域的糖尿病护理设备行业份额将实现 10.4% 的CAGR。这可归因于人们越来越偏爱家庭糖尿病管理，因为这些设备为患者提供了便利性和舒适性。家庭护理患者。不断增长的技术进步鼓励开发适合家庭环境的紧凑且易于使用的设备，进一步促进产品在家庭护理环境中的采用。

从地区来看，由于人们对糖尿病管理的认识不断提高、糖尿病患病率不断上升以及政府支持倡议的推出，预计到 2032 年，欧洲糖尿病护理设备行业规模将以 9.7% 的增长率扩大。创新血糖监测系统和胰岛素输送设备的开发正在提高该地区患者糖尿病管理解决方案的有效性和便利性。

产业生态系统分析
产业影响力
- 成长动力
  - 全球糖尿病盛行率不断上升
  - 糖尿病护理设备不断进步的技术
  - 增加公共和私人组织对糖尿病护理的投资
- 产业陷阱与挑战
  - 糖尿病护理设备成本高
  - 严格的监管框架
成长潜力分析
技术景观
按地区分類的糖尿病盛行率估计和预测
糖尿病管理成本（按地区）
产品管道分析
- 正在研发的糖尿病照护产品，2023 年
报销场景
- 编码和报销
- 胰岛素输送系统的报销政策和公共医疗保健部门保险范围
  - 我们
  - 欧洲
监管环境
- 我们
- 欧洲
技术景观
- 血糖监测系统的进步
- 胰岛素输送装置的进步
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

主要趋势
血糖监测设备
- 自我监测血糖仪
- 连续血糖监测仪
- 测试条
- 柳叶刀
胰岛素输送装置
- 胰岛素帮浦
  - 管式帮浦
  - 无内胎帮浦
- 钢笔
  - 可重复使用的
  - 一次性的
- 笔针
  - 标准
  - 安全
- 注射器
- 其他设备

第 6 章：市场估计与预测：依最终用途，2018 - 2032 年

主要趋势
医院
门诊手术中心
诊断中心
居家护理
其他最终用户

第 7 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 荷兰
- 瑞典
- 比利时
- 丹麦
- 芬兰
- 挪威
- 立陶宛
- 拉脱维亚
- 爱沙尼亚
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 智利
- 秘鲁
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 土耳其
- 埃及
- 以色列
- 科威特
- 卡达
- 中东和非洲其他地区

第 8 章：公司简介

Abbott Laboratories
Arkray, Inc.
Ascensia Diabetes Care Holding AG
B. Braun Melsungen AG
Becton Dickinson and Company
Bionime Corporation
DarioHealth Corp.
Dexcom, Inc.
Dr. Reddy's Laboratories
Eli Lilly and Company
F. Hoffmann-La Roche AG
Insulet Corporation
LifeScan, Inc.
Medtronic Plc
Nova Biomedical, Inc.
Novo Nordisk A/S
Pendiq GmBH
Sanofi
Sinocare, Inc.
Tandem Diabetes Care Inc.
Ypsomed AG

简介目录

Product Code: 3250

Diabetes Care Devices Market size is projected to expand at 10% CAGR from 2024 to 2032, led by the rising prevalence of diabetes globally, owing to sedentary lifestyles and unhealthy dietary habits. According to the CDC, total 38.4 million people in the U.S. have diabetes. Rising technological developments are promoting the development of more efficient and user-friendly devices for improving patient compliance and adoption.

The growing awareness about the importance of regular monitoring and management of blood glucose levels among diabetic patients will escalate the demand for the devices. The implementation of favorable reimbursement policies for diabetes care in many regions and the growing geriatric population prone to diabetes-related complications will also complement the industry progression.

The diabetes care devices market is segregated into product, end-use, and region.

In terms of product, the market value from the insulin delivery devices segment will rise at 10.2% growth rate until 2032. Innovations in technology are resulting in the development of more user-friendly and convenient insulin delivery devices. The increasing prevalence of diabetes globally, coupled with the rising adoption of insulin therapy are accelerating the appeal of insulin delivery devices. The jump in initiatives to enhance patient adherence to insulin therapy will also amplify the product adoption.

Diabetes care devices industry share from the homecare end-use segment is estimated to witness 10.4% CAGR between 2024 and 2032. This can be credited to the increasing preference for home-based management of diabetes due to the convenience and comfort provided by these devices to homecare patients. Growing technology improvements are encouraging development of compact and easy-to-use devices suitable for home settings, further boosting the product adoption in homecare settings.

Regionally, the Europe diabetes care devices industry size is anticipated to expand at 9.7% growth rate until 2032, on account of the increasing awareness about diabetes management, rising prevalence of diabetes, and the rollout of supportive government initiatives. The development of innovative glucose monitoring systems and insulin delivery devices are enhancing the effectiveness and convenience of diabetes management solutions for patients across the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of diabetes across the world
  - 3.2.1.2 Rising technological advancements in diabetes care devices
  - 3.2.1.3 Increasing investments by public and private organizations for diabetes care
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of diabetes care devices
  - 3.2.2.2 Rigorous regulatory framework
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Diabetes prevalence estimates and forecast, by region
3.6 Cost of diabetes management, by region
3.7 Product pipeline analysis
- 3.7.1 Diabetes care products in pipeline, 2023
3.8 Reimbursement scenario
- 3.8.1 Coding and reimbursement
- 3.8.2 Reimbursement policies and public healthcare sector insurance coverage for insulin delivery systems
  - 3.8.2.1 U.S.
  - 3.8.2.2 Europe
3.9 Regulatory landscape
- 3.9.1 U.S.
- 3.9.2 Europe
3.10 Technology landscape
- 3.10.1 Advancements in blood glucose monitoring systems
- 3.10.2 Advancements in insulin delivery devices
3.11 Porter's analysis
- 3.11.1 Supplier power
- 3.11.2 Buyer power
- 3.11.3 Threat of new entrants
- 3.11.4 Threat of substitutes
- 3.11.5 Industry rivalry
3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Blood glucose monitoring devices
- 5.2.1 Self-monitoring blood glucose meters
- 5.2.2 Continuous glucose monitors
- 5.2.3 Testing strips
- 5.2.4 Lancets
5.3 Insulin delivery devices
- 5.3.1 Insulin pumps
  - 5.3.1.1 Tubed pumps
  - 5.3.1.2 Tubeless pumps
- 5.3.2 Pens
  - 5.3.2.1 Reusable
  - 5.3.2.2 Disposable
- 5.3.3 Pen needles
  - 5.3.3.1 Standard
  - 5.3.3.2 Safety
- 5.3.4 Syringes
- 5.3.5 Other devices

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital
6.3 Ambulatory surgical centers
6.4 Diagnostic centers
6.5 Homecare
6.6 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Netherlands
- 7.3.5 Sweden
- 7.3.6 Belgium
- 7.3.7 Denmark
- 7.3.8 Finland
- 7.3.9 Norway
- 7.3.10 Lithuania
- 7.3.11 Latvia
- 7.3.12 Estonia
- 7.3.13 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Colombia
- 7.5.5 Chile
- 7.5.6 Peru
- 7.5.7 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Turkey
- 7.6.5 Egypt
- 7.6.6 Israel
- 7.6.7 Kuwait
- 7.6.8 Qatar
- 7.6.9 Rest of Middle East and Africa